Novartis
Drug makers warn Greek medicine supply 'may be in jeopardy'
Drug makers said on Monday they would continue to ship medicines to Greece in coming weeks, despite mounting unpaid bills, but warned supplies could be in jeopardy if Europe did not take emergency action.
Glaxo in $350 million cancer deal with biotech specialist
British pharmaceuticals giant GlaxoSmithKline has agreed a $350-million deal with Adaptimmune to help develop and sell the biotechnology firm's cancer drugs, the companies said on Monday.